The efficacy and safety of gemcitabine, dexamethasone, and cisplatine (GDP) therapy for relapsed/refractory lymphoma

被引：0
|
作者：
Nozawa, Kazuki [1 ]
Sugiyama, Keiji [1 ]
Hasegawa, Yuta [1 ]
Nakamura, Hiroyuki [1 ]
Hirano, Daiki [1 ]
Tokunaga, Takashi [1 ]
Miyata, Yasuhiko [1 ]
Kunitomi, Akane [1 ]
Ida, Hiroatsu [1 ]
Nagai, Hirokazu [1 ]
机构：
[1] Nagoya Med Ctr, Dept Hematol, Nagoya, Aichi, Japan
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-8-2
引用
收藏
页码：147 / 148
页数：2
相关论文
共 50 条
  • [1] Efficacy and safety of stem cell mobilization following gemcitabine, dexamethasone, cisplatin (GDP) salvage chemotherapy in patients with relapsed or refractory lymphoma
    Tang, Catherine
    Espin-Garcia, Osvaldo
    Prica, Anca
    Kurkreti, Vishal
    Kridel, Robert
    Keating, Armand
    Patriquin, Christopher J.
    Kuruvilla, John
    Crump, Michael
    [J]. LEUKEMIA & LYMPHOMA, 2020, 61 (09) : 2153 - 2160
  • [2] High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin Lymphoma
    Ryszard Swoboda
    Sebastian Giebel
    Wanda Knopińska-Posłuszny
    Ewa Chmielowska
    Joanna Drozd-Sokołowska
    Ewa Paszkiewicz-Kozik
    Waldemar Kulikowski
    Michał Taszner
    Włodzimierz Mendrek
    Jacek Najda
    Tomasz Czerw
    Magdalena Olszewska-Szopa
    Anna Czyż
    Agnieszka Giza
    Wojciech Spychałowicz
    Edyta Subocz
    Paweł Szwedyk
    Aleksandra Krzywon
    Agata Wilk
    Jan Maciej Zaucha
    [J]. Annals of Hematology, 2021, 100 : 1755 - 1767
  • [3] GEMCITABINE, DEXAMETHASONE, AND CISPLATIN (GDP): EFFECTIVE AND WELL-TOLERATED SALVAGE THERAPY FOR RELAPSED/REFRACTORY HODGKIN LYMPHOMA (HL)
    Moccia, A. A.
    Hoskins, P.
    Klasa, R.
    Savage, K. J.
    Shenkier, T.
    Skinnider, B.
    Slack, G.
    Gascoyne, R. D.
    Connors, J. M.
    Sehn, L. H.
    [J]. HAEMATOLOGICA, 2010, 95 : S28 - S29
  • [4] Gemcitabine, dexamethasone, and cisplatin (GDP) as an effective therapy as salvage and mobilization regimen in patients with relapsed or refractory Hodgkin lymphoma.
    Gokmen, Ayla
    Soydan, Ender
    Gokgoz, Zafer
    Kurdal, Mevlude
    Tek, Ibrahim
    Ilhan, Osman
    Arslan, Onder
    Ozcan, Muhit
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] Correction to: High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin lymphoma
    Ryszard Swoboda
    Sebastian Giebel
    Wanda Knopińska-Posłuszny
    Ewa Chmielowska
    Joanna Drozd-Sokołowska
    Ewa Paszkiewicz-Kozik
    Waldemar Kulikowski
    Michał Taszner
    Włodzimierz Mendrek
    Jacek Najda
    Tomasz Czerw
    Magdalena Olszewska-Szopa
    Anna Czyż
    Agnieszka Giza
    Wojciech Spychałowicz
    Edyta Subocz
    Paweł Szwedyk
    Aleksandra Krzywon
    Agata Wilk
    Jan Maciej Zaucha
    [J]. Annals of Hematology, 2021, 100 : 1919 - 1919
  • [6] Efficacy and safety of gemcitabine containing regimen for refractory and relapsed non-Hodgkin lymphoma
    Mizutani, Chisato
    Nishi, Katsuyuki
    Takahashi, Satoshi
    Mitani, Sachiko
    Tada, Kohei
    Kaneko, Hitomi
    Hatanaka, Kazuo
    Ukyo, Naoya
    Hirata, Hirokazu
    Tsudo, Mituru
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 147 - 147
  • [7] Gemcitabine, carboplatin, and dexamethasone as salvage chemotherapy for outpatients with relapsed or refractory lymphoma
    Iino, Masaki
    Yamamoto, Takeo
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [8] Gemcitabine, dexamethasone, and cisplatin (GDP) is an effective and well-tolerated salvage therapy for relapsed/refractory diffuse large B-cell lymphoma and Hodgkin lymphoma
    Moccia, Alden A.
    Hitz, Felicitas
    Hoskins, Paul
    Klasa, Richard
    Power, Maryse M.
    Savage, Kerry J.
    Shenkier, Tamara
    Shepherd, John D.
    Slack, Graham W.
    Song, Kevin W.
    Gascoyne, Randy D.
    Connors, Joseph M.
    Sehn, Laurie H.
    [J]. LEUKEMIA & LYMPHOMA, 2017, 58 (02) : 324 - 332
  • [9] Gemcitabine, dexamethasone, and cisplatin (GDP) as salvage chemotherapy for patients with relapsed or refractory peripheral T cell lymphoma—not otherwise specified
    Fei Qi
    Mei Dong
    Xiaohui He
    Yexiong Li
    Weihu Wang
    Peng Liu
    Jianliang Yang
    Lin Gui
    Changgong Zhang
    Sheng Yang
    Shengyu Zhou
    Yuankai Shi
    [J]. Annals of Hematology, 2017, 96 : 245 - 251
  • [10] EFFICACY OF GEMCITABINE AS SALVAGE THERAPY FOR RELAPSED/REFRACTORY AGGRESSIVE NON HODGKIN LYMPHOMA PATIENTS
    Zlotnick, M.
    Avigdor, A.
    Ribakovsky, E.
    Nagler, A.
    Kedmi, M.
    [J]. HAEMATOLOGICA, 2016, 101 : 696 - 696
12345